[Safety of the proton pump inhibitors].

Research output: Contribution to journalScientific reviewpeer-review

3 Scopus citations


Proton Pump Inhibitors (PPI) are consumed by millions of people around the world, either by prescription or self-medication, some medications of this group are Over-the-counter (OTC) medicines. PPIs have been associated with hypergastrinemia, rebound acid hypersecretion, malabsorption, osteoporosis and infections. This is an updated review of clinical pharmacology aspects of IPBS, with emphasis on safety aspects.
Original languageAmerican English
Pages (from-to)49-55
Number of pages7
JournalRevista de gastroenterología del Perú : órgano oficial de la Sociedad de Gastroenterología del Perú
StatePublished - 1 Jan 2011


Dive into the research topics of '[Safety of the proton pump inhibitors].'. Together they form a unique fingerprint.

Cite this